Back
Amicus Therapeutics Vs. Fabrinet Industry Stock Comparison
Sell
35
FOLD
Amicus Therapeutics
Last Price:
$8.89
Seasonality Move:
5.08%
Buy
74
FN
Fabrinet
Last Price:
$220.16
Seasonality Move:
2.27%
Sell
35
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy, Sell or Hold?
-
The current Amicus Therapeutics [FOLD] share price is $8.81. The Score for FOLD is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
FOLD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FOLD Stock Price Chart
What is Amicus Therapeutics's stock price today?
-
The Amicus Therapeutics share price today is $8.81Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight selling pressure.
FN Stock Price Chart
FOLD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 39.39 | Sell |
Chaikin Money Flow: | -348892 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9 - 9.68) | Sell |
Bollinger Bands (100): | (9.13 - 10.71) | Sell |
FN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.43 | Sell |
Relative Strength Index (14 RSI): | 56.36 | Buy |
Chaikin Money Flow: | 370714 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (195.23 - 224.51) | Buy |
Bollinger Bands (100): | (211.34 - 249.88) | Sell |
FOLD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.98 | Sell |
20-day SMA: | 9.24 | Sell |
50-day SMA: | 9.4 | Sell |
200-day SMA: | 10.26 | Sell |
8-day EMA: | 8.97 | Sell |
20-day EMA: | 9.17 | Sell |
50-day EMA: | 9.44 | Sell |
200-day EMA: | 10.23 | Sell |
FN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 197.43 | Buy |
20-day SMA: | 209.1 | Buy |
50-day SMA: | 219.48 | Buy |
200-day SMA: | 232.93 | Sell |
8-day EMA: | 203.8 | Buy |
20-day EMA: | 207.34 | Buy |
50-day EMA: | 216.8 | Buy |
200-day EMA: | 221.88 | Buy |
Amicus Therapeutics Earnings Growth & FOLD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.27 per share, and an increase next year of $0.33 per share.
Fabrinet Earnings Growth & FN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.02 per share, an increase this year of $1.57 per share, and an increase next year of $1.32 per share.
Amicus Therapeutics Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Fabrinet Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |